Ingrid van Beek

3.6k total citations
68 papers, 2.8k citations indexed

About

Ingrid van Beek is a scholar working on Epidemiology, Hepatology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Ingrid van Beek has authored 68 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Epidemiology, 24 papers in Hepatology and 18 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Ingrid van Beek's work include HIV, Drug Use, Sexual Risk (30 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (19 papers). Ingrid van Beek is often cited by papers focused on HIV, Drug Use, Sexual Risk (30 papers), Hepatitis C virus research (24 papers) and Hepatitis B Virus Studies (19 papers). Ingrid van Beek collaborates with scholars based in Australia, United States and Canada. Ingrid van Beek's co-authors include John Kaldor, Alex Wodak, Gregory J. Dore, Robyn Dwyer, Richard P. Mattick, James Shearer, Stuart Gilmour, Jo Kimber, Lisa Maher and Janaki Amin and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Ingrid van Beek

66 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid van Beek Australia 33 2.0k 1.1k 743 592 344 68 2.8k
Rebecca Jenkinson Australia 26 922 0.5× 229 0.2× 494 0.7× 135 0.2× 279 0.8× 51 1.6k
Craig Fry Australia 26 1.1k 0.5× 94 0.1× 984 1.3× 197 0.3× 527 1.5× 86 2.2k
Thomas Reisch Switzerland 28 729 0.4× 789 0.7× 312 0.4× 430 0.7× 138 0.4× 71 2.5k
V. Anna Gyarmathy United States 24 963 0.5× 241 0.2× 324 0.4× 473 0.8× 254 0.7× 73 1.4k
Caryl Beynon United Kingdom 23 690 0.3× 111 0.1× 322 0.4× 96 0.2× 351 1.0× 66 1.6k
Mary Ellen Mackesy‐Amiti United States 23 838 0.4× 73 0.1× 324 0.4× 492 0.8× 473 1.4× 80 1.6k
Paul K Nelson Australia 10 956 0.5× 741 0.7× 157 0.2× 234 0.4× 114 0.3× 14 1.4k
Georgina J MacArthur United Kingdom 16 835 0.4× 119 0.1× 479 0.6× 296 0.5× 316 0.9× 28 1.5k
John Dunn Brazil 24 724 0.4× 61 0.1× 210 0.3× 225 0.4× 205 0.6× 60 1.7k
Bernd Schulte Germany 22 960 0.5× 182 0.2× 297 0.4× 100 0.2× 551 1.6× 109 1.8k

Countries citing papers authored by Ingrid van Beek

Since Specialization
Citations

This map shows the geographic impact of Ingrid van Beek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid van Beek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid van Beek more than expected).

Fields of papers citing papers by Ingrid van Beek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid van Beek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid van Beek. The network helps show where Ingrid van Beek may publish in the future.

Co-authorship network of co-authors of Ingrid van Beek

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid van Beek. A scholar is included among the top collaborators of Ingrid van Beek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid van Beek. Ingrid van Beek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beek, Ingrid van, et al.. (2015). Surveillance of injecting‐related injury and diseases in people who inject drugs attending a targeted primary health care facility in Sydney's Kings Cross. Australian and New Zealand Journal of Public Health. 39(2). 182–187. 9 indexed citations
2.
Alavi, Maryam, Tim Spelman, Gail Matthews, et al.. (2015). Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C. International Journal of Drug Policy. 26(10). 976–983. 32 indexed citations
3.
Topp, Libby, Carolyn Day, Handan Wand, et al.. (2013). A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Preventive Medicine. 57(4). 297–303. 50 indexed citations
4.
Beek, Ingrid van, et al.. (2012). SYDNEY NALOXONE DISTRIBUTION PROGRAM - WHAT CLINICIANS AND CLIENTS THINK. Drug and Alcohol Review. 31. 55–55. 4 indexed citations
5.
Alavi, Maryam, Jason Grebely, Gail Matthews, et al.. (2012). Effect of pegylated interferon-alpha-2a treatment on mental health during recent hepatitis C virus infection. Hepatology. 27(5). 5 indexed citations
6.
Salmon, Allison M., Ingrid van Beek, Janaki Amin, John Kaldor, & Lisa Maher. (2010). The impact of a supervised injecting facility on ambulance call‐outs in Sydney, Australia. Addiction. 105(4). 676–683. 68 indexed citations
7.
Day, Carolyn, Bethany White, Gregory J. Dore, et al.. (2010). Hepatitis B virus among injecting drug users in Sydney, Australia: Prevalence, vaccination and knowledge of status. Drug and Alcohol Dependence. 108(1-2). 134–137. 17 indexed citations
8.
Grebely, Jason, Gail Matthews, Margaret Hellard, et al.. (2010). Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users. Journal of Hepatology. 55(1). 76–85. 46 indexed citations
9.
Shearer, James, Marian Shanahan, Shane Darke, et al.. (2010). A cost‐effectiveness analysis of modafinil therapy for psychostimulant dependence. Drug and Alcohol Review. 29(3). 235–242. 12 indexed citations
10.
Dore, Gregory J., Margaret Hellard, Gail Matthews, et al.. (2009). Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection. Gastroenterology. 138(1). 123–135.e2. 115 indexed citations
11.
Kimber, Jo, Richard P. Mattick, John Kaldor, et al.. (2008). Process and predictors of drug treatment referral and referral uptake at the Sydney Medically Supervised Injecting Centre. Drug and Alcohol Review. 27(6). 602–612. 53 indexed citations
12.
Webster, Ian, et al.. (2008). Infectious diseases in homeless people. New South Wales Public Health Bulletin. 19(4). 76–76. 1 indexed citations
13.
White, Bethany, Carolyn Day, Hla‐Hla Thein, et al.. (2008). Acceptability of hepatitis C virus testing methods among injecting drug users. Drug and Alcohol Review. 27(6). 666–670. 19 indexed citations
14.
Degenhardt, Louisa, Amanda Roxburgh, Ingrid van Beek, et al.. (2008). The effects of the market withdrawal of temazepam gel capsules on benzodiazepine injecting in Sydney, Australia. Drug and Alcohol Review. 27(2). 145–151. 15 indexed citations
15.
Beek, Ingrid van. (2007). Case study: Accessible primary health care—A foundation to improve health outcomes for people who inject drugs. International Journal of Drug Policy. 18(4). 329–332. 36 indexed citations
16.
Treloar, Carla, et al.. (2007). Broadening discussions of “safe” in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice. International Journal of Drug Policy. 19(1). 59–65. 23 indexed citations
17.
Beek, Ingrid van, John B. Saunders, & Ann Roche. (2006). The Australasian Professional Society on Alcohol and Other Drugs: from a cottage industry to a regional player. Addiction. 102(2). 191–196. 2 indexed citations
18.
Micallef, J., Virginia Macdonald, Marianne Jauncey, et al.. (2006). High incidence of hepatitis C virus reinfection within a cohort of injecting drug users. Journal of Viral Hepatitis. 14(6). 413–418. 88 indexed citations
19.
Jauncey, Marianne, J. Micallef, Stuart Gilmour, et al.. (2004). Clearance of Hepatitis C Virus after Newly Acquired Infection in Injection Drug Users. The Journal of Infectious Diseases. 190(7). 1270–1274. 61 indexed citations
20.
Thackway, Sarah, Virginia Furner, Anne Mijch, et al.. (1997). Fertility and reproductive choice in women with HIV-1 infection. AIDS. 11(5). 663–667. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rebecca Jenkinson Breakdown of academic impact, for papers by Craig Fry Breakdown of academic impact, for papers by Thomas Reisch Breakdown of academic impact, for papers by V. Anna Gyarmathy Breakdown of academic impact, for papers by Caryl Beynon Breakdown of academic impact, for papers by Mary Ellen Mackesy‐Amiti Breakdown of academic impact, for papers by Paul K Nelson Breakdown of academic impact, for papers by Georgina J MacArthur Breakdown of academic impact, for papers by John Dunn Breakdown of academic impact, for papers by Bernd Schulte
Rankless by CCL
2026